We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

The RESP Program organizes and supports numerous speakers, seminars, and symposia throughout the year.

The Meakins-Christie Laboratories is one of the premier centres for pulmonary research in Canada, whose mission is to understand the pathobiology of respiratory disorders and to drive innovations in respiratory disease prevention, diagnosis, and therapy.

The Respiratory Epidemiology and Clinical Research Unit (RECRU) is a leading centre for epidemiological research, clinical trials, and economic analyses. It conducts clinical and community-based research studies.

The McGill TB Centre is a world leader in the study of TB, bringing together research expertise in epidemiology, policy setting, economic analyses, implementation research, meta-analyses, qualitative research and basic science including microbiology, host genetics and immune response.

The McGill Research Centre for Cannabis incorporates multidisciplinary research in plant science, production and processing, disease models and preclinical research, drug development and clinical trials, as well as social implications and health and economic impact studies.

The Biobank of the Quebec Respiratory Health Research Network (RSRQ) is a common resource spread over several participating centers to provide high quality, well documented biological materials, essential for improving the understanding of respiratory disease.

The MUHC COVID-19 Biobank is an integral part of the Biobanque québécoise de la COVID-19 (BQC), providing state-of the-art infrastructure and the research expertise required to collect, store and share biological samples and medical data from people infected with COVID-19.

The mission of the McGill University Health Centre Consortium for Rare Disease (MUHC-CRDR) is to facilitate patient-oriented, collaborative, trans-disciplinary healthcare and research in Rare Diseases across the lifespan.

CanCOLD is a collaborative Canada-wide study advancing knowledge of why people develop COPD, how and why COPD impacts individuals differently, and how to provide better care for people affected by this disease.

The McGill Centre for Microbiome Research supports microbiome research activities and outcomes to generate evidence-based knowledge for the benefit of medicine and public health.